Houseviews: Trading tips on four stocks ahead of weekend
Published on Thu, May 31, 2012 at 00:00 |  Source :

BIOCON

Brokerage: Merrill Lynch

Rating: DOWNGRADED

Target:  Rs 260

Rationale: Base business outlook is weaker due to increased competition in bio-pharma and lower licensing income.

Showing4 / 4

  

Trending News

Business News

Latest Slide Shows
Most Popular Slide Shows